• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

3Rs for innovating novel antibiotics: sharing resources, risks, and rewards.

作者信息

So Anthony D, Ruiz-Esparza Quentin, Gupta Neha, Cars Otto

机构信息

Program on Global Health and Technology Access, Sanford School of Public Policy, Duke University, Durham, NC 27708, USA.

出版信息

BMJ. 2012 Apr 3;344:e1782. doi: 10.1136/bmj.e1782.

DOI:10.1136/bmj.e1782
PMID:22491076
Abstract
摘要

相似文献

1
3Rs for innovating novel antibiotics: sharing resources, risks, and rewards.创新新型抗生素的3R原则：资源共享、风险共担、回报均分。
BMJ. 2012 Apr 3;344:e1782. doi: 10.1136/bmj.e1782.
2
New business models for antibiotic innovation.抗生素创新的新商业模式。
Ups J Med Sci. 2014 May;119(2):176-80. doi: 10.3109/03009734.2014.898717. Epub 2014 Mar 19.
3
Opening up to precompetitive collaboration.开放竞争前合作。
Sci Transl Med. 2010 Oct 6;2(52):52cm26. doi: 10.1126/scitranslmed.3001515.
4
A call for sharing: adapting pharmaceutical research to new realities.呼吁共享：使药物研究适应新现实。
Sci Transl Med. 2009 Dec 2;1(9):9cm8. doi: 10.1126/scitranslmed.3000155.
5
Where does novel antibiotics R&D stand among other pharmaceutical products: an industrial perspective?从行业角度看，新型抗生素研发在其他药品研发中处于什么位置？
Expert Rev Anti Infect Ther. 2008 Oct;6(5):551-2. doi: 10.1586/14787210.6.5.551.
6
Public-private partnerships in drug development for underdeveloped countries: an interview with Craig Wheeler, President of Chiron's Biopharmaceutical Division. Interview by Thomasine Kushner.为欠发达国家开展药物研发的公私合作关系：对凯龙生物制药部门总裁克雷格·惠勒的访谈。托马斯ine·库什纳采访。
Camb Q Healthc Ethics. 2003 Fall;12(4):429-33.
7
Collaboration studies co-receptor drug research.
AIDS Patient Care STDS. 1998 Mar;12(3):230.
8
Resistance to antibiotics: are we in the post-antibiotic era?抗生素耐药性：我们处于后抗生素时代吗？
Arch Med Res. 2005 Nov-Dec;36(6):697-705. doi: 10.1016/j.arcmed.2005.06.009.
9
Testing antibiotics and chemotherapeutic agents. The drug, the manufacturer and the university hospitals.
J Iowa Med Soc. 1966 Apr;56(4):368-78.
10
Antibiotics: where did we go wrong?抗生素：我们哪里出错了？
Drug Discov Today. 2005 Jan 1;10(1):45-52. doi: 10.1016/S1359-6446(04)03285-4.

引用本文的文献

1
'Piloting a framework for analysing the public contributions to R&D: new antibiotics in focus'.试行一个分析公众对研发贡献的框架：聚焦新型抗生素
J Pharm Policy Pract. 2025 Jan 21;18(1):2449045. doi: 10.1080/20523211.2024.2449045. eCollection 2025.
2
Achieving sustainable access to antibiotics is more than just a last mile challenge.实现抗生素的可持续供应不仅仅是最后一公里的挑战。
Nat Rev Microbiol. 2024 Oct;22(10):593-594. doi: 10.1038/s41579-024-01083-5.
3
A Core Element and Shared Global Responsibility for Pandemic Preparedness and Response.
大流行防范和应对的核心要素和共同全球责任。
J Law Med Ethics. 2022;50(S2):34-39. doi: 10.1017/jme.2022.77.
4
The Resistance Patterns in Isolates among Apparently Healthy Adults and Local Drivers of Antimicrobial Resistance: A Mixed-Methods Study in a Suburban Area of Nepal.尼泊尔郊区健康成年人中分离株的耐药模式及抗菌药物耐药性的本地驱动因素：一项混合方法研究
Trop Med Infect Dis. 2022 Jul 12;7(7):133. doi: 10.3390/tropicalmed7070133.
5
Setting the standard: multidisciplinary hallmarks for structural, equitable and tracked antibiotic policy.设定标准：结构、公平和跟踪抗生素政策的多学科标志。
BMJ Glob Health. 2020 Sep;5(9). doi: 10.1136/bmjgh-2020-003091.
6
The Ethical Significance of Antimicrobial Resistance.抗菌药物耐药性的伦理意义。
Public Health Ethics. 2015 Nov;8(3):209-224. doi: 10.1093/phe/phv025. Epub 2015 Sep 30.
7
The political and ethical challenge of multi-drug resistant tuberculosis.耐多药结核病的政治与伦理挑战
J Bioeth Inq. 2015 Mar;12(1):107-13. doi: 10.1007/s11673-014-9595-3. Epub 2015 Jan 29.
8
Bio-threat preparedness: Need for a paradigm shift.生物威胁防范：范式转变的必要性。
Med J Armed Forces India. 2014 Apr;70(2):170-4. doi: 10.1016/j.mjafi.2013.05.007. Epub 2014 Mar 6.
9
The need to look at antibiotic resistance from a health systems perspective.需要从卫生系统的角度来看待抗生素耐药性。
Ups J Med Sci. 2014 May;119(2):117-24. doi: 10.3109/03009734.2014.902879. Epub 2014 Mar 27.
10
Overcoming scientific and structural bottlenecks in antibacterial discovery and development.克服抗菌药物发现和开发中的科学和结构瓶颈。
Ups J Med Sci. 2014 May;119(2):170-5. doi: 10.3109/03009734.2014.897277. Epub 2014 Mar 19.